These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 23661642)

  • 1. Structure of parkin reveals mechanisms for ubiquitin ligase activation.
    Trempe JF; Sauvé V; Grenier K; Seirafi M; Tang MY; Ménade M; Al-Abdul-Wahid S; Krett J; Wong K; Kozlov G; Nagar B; Fon EA; Gehring K
    Science; 2013 Jun; 340(6139):1451-5. PubMed ID: 23661642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin.
    Hristova VA; Beasley SA; Rylett RJ; Shaw GS
    J Biol Chem; 2009 May; 284(22):14978-86. PubMed ID: 19339245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease.
    Beasley SA; Hristova VA; Shaw GS
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3095-100. PubMed ID: 17360614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive computational study on pathogenic mis-sense mutations spanning the RING2 and REP domains of Parkin protein.
    Biswas R; Bagchi A
    Gene; 2017 Apr; 610():49-58. PubMed ID: 28189762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the human Parkin ligase domain in an autoinhibited state.
    Wauer T; Komander D
    EMBO J; 2013 Jul; 32(15):2099-112. PubMed ID: 23727886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated RING2 domain of parkin is sufficient for E2-dependent E3 ligase activity.
    Rankin CA; Galeva NA; Bae K; Ahmad MN; Witte TM; Richter ML
    Biochemistry; 2014 Jan; 53(1):225-34. PubMed ID: 24328108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular explanation for the recessive nature of parkin-linked Parkinson's disease.
    Spratt DE; Martinez-Torres RJ; Noh YJ; Mercier P; Manczyk N; Barber KR; Aguirre JD; Burchell L; Purkiss A; Walden H; Shaw GS
    Nat Commun; 2013; 4():1983. PubMed ID: 23770917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Ubl/ubiquitin switch in the activation of Parkin.
    Sauvé V; Lilov A; Seirafi M; Vranas M; Rasool S; Kozlov G; Sprules T; Wang J; Trempe JF; Gehring K
    EMBO J; 2015 Oct; 34(20):2492-505. PubMed ID: 26254305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional feedforward mechanism of Parkin activation via binding of phospho-UBL and RING0 in
    Lenka DR; Dahe SV; Antico O; Sahoo P; Prescott AR; Muqit MMK; Kumar A
    Elife; 2024 Sep; 13():. PubMed ID: 39221915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of parkin activation by phosphorylation.
    Sauvé V; Sung G; Soya N; Kozlov G; Blaimschein N; Miotto LS; Trempe JF; Lukacs GL; Gehring K
    Nat Struct Mol Biol; 2018 Jul; 25(7):623-630. PubMed ID: 29967542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation by PINK1 releases the UBL domain and initializes the conformational opening of the E3 ubiquitin ligase Parkin.
    Caulfield TR; Fiesel FC; Moussaud-Lamodière EL; Dourado DF; Flores SC; Springer W
    PLoS Comput Biol; 2014 Nov; 10(11):e1003935. PubMed ID: 25375667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A disease state mutation unfolds the parkin ubiquitin-like domain.
    Safadi SS; Shaw GS
    Biochemistry; 2007 Dec; 46(49):14162-9. PubMed ID: 18004887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis of the effects of mutations in Ubl domain of Parkin leading to Parkinson's disease.
    Biswas S; Roy R; Biswas R; Bagchi A
    Gene; 2020 Feb; 726():144186. PubMed ID: 31647998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.
    Yao D; Gu Z; Nakamura T; Shi ZQ; Ma Y; Gaston B; Palmer LA; Rockenstein EM; Zhang Z; Masliah E; Uehara T; Lipton SA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10810-4. PubMed ID: 15252205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of phospho-ubiquitin-induced PARKIN activation.
    Wauer T; Simicek M; Schubert A; Komander D
    Nature; 2015 Aug; 524(7565):370-4. PubMed ID: 26161729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of altered phosphorylation on loss of function of juvenile Parkinsonism-associated genetic variants of the E3 ligase parkin.
    Aguirre JD; Dunkerley KM; Lam R; Rusal M; Shaw GS
    J Biol Chem; 2018 Apr; 293(17):6337-6348. PubMed ID: 29530980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic recruitment of UbcH7~Ub and phosphorylated Ubl domain triggers parkin activation.
    Condos TE; Dunkerley KM; Freeman EA; Barber KR; Aguirre JD; Chaugule VK; Xiao Y; Konermann L; Walden H; Shaw GS
    EMBO J; 2018 Dec; 37(23):. PubMed ID: 30446597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the E3 ubiquitin ligase Parkin.
    Caulfield TR; Fiesel FC; Springer W
    Biochem Soc Trans; 2015 Apr; 43(2):269-74. PubMed ID: 25849928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the autoinhibited state primes the E3 ligase parkin for activation and catalysis.
    Kumar A; Aguirre JD; Condos TE; Martinez-Torres RJ; Chaugule VK; Toth R; Sundaramoorthy R; Mercier P; Knebel A; Spratt DE; Barber KR; Shaw GS; Walden H
    EMBO J; 2015 Oct; 34(20):2506-21. PubMed ID: 26254304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the C-terminal RING finger from a RING-IBR-RING/TRIAD motif reveals a novel zinc-binding domain distinct from a RING.
    Capili AD; Edghill EL; Wu K; Borden KL
    J Mol Biol; 2004 Jul; 340(5):1117-29. PubMed ID: 15236971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.